Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis

J Neuroimmunol. 2017 Mar 15:304:56-62. doi: 10.1016/j.jneuroim.2016.07.005. Epub 2016 Jul 17.

Abstract

Several years following its discovery in 1980, infection with human T-lymphotropic virus type 1 (HTLV-1) was shown to cause HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP), a disease biologically similar to progressive forms of multiple sclerosis (MS). In this manuscript, we review some of the clinical, pathological, and immunological similarities between HAM/TSP and MS with an emphasis on how autoantibodies to an RNA binding protein, heterogeneous nuclear ribonuclear protein A1 (hnRNP A1), might contribute to neurodegeneration in immune mediated diseases of the central nervous system.

Keywords: Autoimmunity; HTLV-1; Multiple sclerosis; Neurodegeneration; RNA; RNA binding protein.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoantibodies / immunology*
  • Heterogeneous Nuclear Ribonucleoprotein A1
  • Heterogeneous-Nuclear Ribonucleoprotein Group A-B / immunology*
  • Humans
  • Multiple Sclerosis, Chronic Progressive / immunology*
  • Multiple Sclerosis, Chronic Progressive / pathology
  • Neurodegenerative Diseases / immunology
  • Neurodegenerative Diseases / pathology
  • Paraparesis, Tropical Spastic / immunology*
  • Paraparesis, Tropical Spastic / pathology

Substances

  • Autoantibodies
  • Heterogeneous Nuclear Ribonucleoprotein A1
  • Heterogeneous-Nuclear Ribonucleoprotein Group A-B
  • hnRNPA1 protein, human